May 2 |
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
|
May 2 |
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
|
May 2 |
United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...
|
May 2 |
Q1 2024 United Therapeutics Corp Earnings Call
|
May 1 |
Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
|
May 1 |
United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript
|
May 1 |
Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics
|
May 1 |
United Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
|
May 1 |
United Therapeutics GAAP EPS of $6.17 beats by $0.51, revenue of $677.7M beats by $53.51M
|
May 1 |
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
|